• Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace

    Bio-IT World Brief | During the AWS re:Invent, Edico Genome revealed its DRAGEN Complete Suite on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN's applications for next-generation sequencing data analysis in one click.

    Dec 1, 2017

  • AWS Adds Capabilities For Amazon Aurora And Amazon DynamoDB, Introduces Amazon Neptune

    Bio-IT World Brief | Yesterday at AWS re:Invent, Amazon Web Services (AWS) announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, a new fully managed graph database service.

    Nov 30, 2017

  • A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own

    Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.

    Nov 29, 2017

  • AI Exposes Patterns For Faster Drug Discovery

    Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.

    Nov 29, 2017

  • A Grim Future? Here Are the Numbers

    In the Pipeline | Here's a bracing look at the state of the pharma business, especially regarding R&D costs and return on investment. And let me warn you - it's not a feel-good outlook.

    Nov 28, 2017

  • 750 Raspberry Pis Turned Into Supercomputer for Los Alamos National Laboratory

    ExtremeTech | A new project at the Los Alamos National Laboratory's High Performance Computing Division seeks to make supercomputers more accessible with help from Raspberry Pi clusters.

    Nov 28, 2017

  • Gene Therapy Hits A Peculiar Roadblock: A Virus Shortage

    The New York Times | Revolutionary new treatments depend on tailor-made viruses, but laboratories cannot make them fast enough.

    Nov 27, 2017

  • Three IT Tracks At Tri-Con Dig Deep Into Cloud, Data Commons, FAIR Data

    Bio-IT World | The Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks coming from the conference we’ve marked so far.

    Nov 27, 2017

  • Senator Calls For More Scrutiny Of Home DNA Test Industry

    NBC News | With the holiday season in full swing, Sen. Chuck Schumer said customers may be putting their genetic information at risk of being sold to third parties.

    Nov 27, 2017

  • Multiple Myeloma Data Analysis Shows Need For Diversity In Research

    Bio-IT World | An analysis of data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study by researchers from the Keck School of Medicine of the University of Southern California (USC) Department of Translational Genomics found significant genetic mutation differences between African Americans and Caucasians with multiple myeloma. African American patients showed increased mutations in genes previously unassociated with multiple myeloma. The findings were published today in PLoS Genetics.

    Nov 22, 2017

  • Tackling The Internet Of Things In Healthcare

    Bio-IT World | Cambridge Healthtech Institute's Inaugural Healthcare Internet of Things event in San Francisco next February aims to bring together constituents and stakeholders to share cases studies and pilot programs that showcase the healthcare industry’s collaborative efforts toward the adoption and implementation of IoT. Here are a few of the talks we have flagged on our agendas.

    Nov 22, 2017

  • Sensors Could Identify Biomarkers, Improve Early-Stage Detection, Treatment Of Diseases

    Bio-IT World Brief | Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections, and different medical conditions at early stages.

    Nov 21, 2017

  • Gene Drives Aren’t Safe Enough To Trial Right Now

    MIT Technology Review | Technology's answer to invasive species and disease-spreading insects is looking riskier than ever in its current form.

    Nov 17, 2017

  • The Big Idea Behind Big Data

    NPR.org | As we find our way in a world shaped by Big Data, it's not the reams of information we gather but the networks they illuminate that's the newest addition to science's index of things.

    Nov 17, 2017

  • In Search For Alzheimer's Drugs, Researchers Must Go Beyond Beta Amyloid

    STAT | In the search for Alzheimer's drugs, it's time to pay more attention to drugs that go beyond targeting beta amyloid, a protein linked to the disease.

    Nov 17, 2017

  • African scientists get their own open-access publishing platform

    Nature News & Comment | Venture will launch next year and seeks to strengthen continent's science by helping academics share work more quickly.

    Nov 15, 2017

  • US Scientists Try 1st Gene Editing In The Body

    AP News | Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease.

    Nov 15, 2017

  • Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx And Expanded Use Of MiSeqDx

    Bio-IT World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.

    Nov 15, 2017

  • Genomics’ Role In Global Pathogen Surveillance, Diagnosis

    Bio-IT World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.

    Nov 14, 2017

  • Wiping Out Alzheimers Is Personal To Microsofts Bill Gates And Paul Allen

    Forbes | Bill Gates announced today that he will invest $50 million of his own money in the Dementia Discovery Fund. Gates has a different approach to funding Alzheimer's research than does Allen, his Microsoft co-founder, but the two are similar in their motives and beliefs about what it's going to take to conquer the disease.

    Nov 13, 2017